Company: PTHS
Filing Date: 2025-08-28
Form Type: S-3
Source: 0001753926-25-001403
Chunk: 88

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-28
Form: S-3
Chunk 88
---
 dollar value of the securities offered would not exceed that which was registered) and any deviation          
 from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the          
 Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent          
 no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee”                
 table in the effective registration statement; and                                                                                  |

| (iii) | To                                                                                                                                
 include any material information with respect to the plan of distribution not previously disclosed in this registration statement 
 or any material change to such information in this registration statement;                                                        |

provided, however, that the undertakings set forth in paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended, that are incorporated by reference in this registration statement or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of this registration statement;

| (b) | That,                                                                                                                              
 for the purpose of determining any liability under the Securities Act of 1933, as amended, each such post-effective amendment      
 shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities 
 at that time shall be deemed to be the initial bona fide offering thereof;                                                         |

| (c) | To                                                                                                                         
 remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold 
 at the termination of the offering;                                                                                        |

| (d) | That,                                                                                                    
 for the purpose of determining liability under the Securities Act of 1933, as amended, to any purchaser: |

| (i) | Each                                                                                                                        
 prospectus filed by the registrant pursuant to Rule 424 (b)(3) shall be deemed to be part of this registration statement as 
 of the date the filed prospectus was deemed part of and included in this registration statement; and                        |

| (ii) | Each                                                                                                                                
 prospectus required to be filed pursuant to Rule 424 (b)(2), (b)(5), or (b)(7) as part